196 related articles for article (PubMed ID: 21301865)
1. Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
Zupančič D; Ovčak Z; Vidmar G; Romih R
Virchows Arch; 2011 May; 458(5):603-13. PubMed ID: 21301865
[TBL] [Abstract][Full Text] [Related]
2. Expression and localization of four uroplakins in urothelial preneoplastic lesions.
Zupančič D; Zakrajšek M; Zhou G; Romih R
Histochem Cell Biol; 2011 Oct; 136(4):491-500. PubMed ID: 21853341
[TBL] [Abstract][Full Text] [Related]
3. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
Ogawa K; St John M; Luiza de Oliveira M; Arnold L; Shirai T; Sun TT; Cohen SM
Toxicol Pathol; 1999; 27(6):645-51. PubMed ID: 10588545
[TBL] [Abstract][Full Text] [Related]
4. Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?
Riedel I; Liang FX; Deng FM; Tu L; Kreibich G; Wu XR; Sun TT; Hergt M; Moll R
Eur J Cell Biol; 2005 Mar; 84(2-3):393-405. PubMed ID: 15819416
[TBL] [Abstract][Full Text] [Related]
5. Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells.
Wu XR; Medina JJ; Sun TT
J Biol Chem; 1995 Dec; 270(50):29752-9. PubMed ID: 8530366
[TBL] [Abstract][Full Text] [Related]
6. Uroplakin gene expression by normal and neoplastic human urothelium.
Lobban ED; Smith BA; Hall GD; Harnden P; Roberts P; Selby PJ; Trejdosiewicz LK; Southgate J
Am J Pathol; 1998 Dec; 153(6):1957-67. PubMed ID: 9846985
[TBL] [Abstract][Full Text] [Related]
7. Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia.
Xie B; Zhou G; Chan SY; Shapiro E; Kong XP; Wu XR; Sun TT; Costello CE
J Biol Chem; 2006 May; 281(21):14644-53. PubMed ID: 16567801
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
[TBL] [Abstract][Full Text] [Related]
9. Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking.
Hu CC; Liang FX; Zhou G; Tu L; Tang CH; Zhou J; Kreibich G; Sun TT
Mol Biol Cell; 2005 Sep; 16(9):3937-50. PubMed ID: 15958488
[TBL] [Abstract][Full Text] [Related]
10. Formation of asymmetric unit membrane during urothelial differentiation.
Sun TT; Zhao H; Provet J; Aebi U; Wu XR
Mol Biol Rep; 1996; 23(1):3-11. PubMed ID: 8983014
[TBL] [Abstract][Full Text] [Related]
11. Selective binding of lectins to normal and neoplastic urothelium in rat and mouse bladder carcinogenesis models.
Zupančič D; Kreft ME; Romih R
Protoplasma; 2014 Jan; 251(1):49-59. PubMed ID: 23828036
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.
Osman I; Kang M; Lee A; Deng FM; Polsky D; Mikhail M; Chang C; David DA; Mitra N; Wu XR; Sun TT; Bajorin DF
Int J Cancer; 2004 Oct; 111(6):934-9. PubMed ID: 15300806
[TBL] [Abstract][Full Text] [Related]
13. Origin of the tetraspanin uroplakins and their co-evolution with associated proteins: implications for uroplakin structure and function.
Garcia-España A; Chung PJ; Zhao X; Lee A; Pellicer A; Yu J; Sun TT; Desalle R
Mol Phylogenet Evol; 2006 Nov; 41(2):355-67. PubMed ID: 16814572
[TBL] [Abstract][Full Text] [Related]
14. Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition.
Liang FX; Riedel I; Deng FM; Zhou G; Xu C; Wu XR; Kong XP; Moll R; Sun TT
Biochem J; 2001 Apr; 355(Pt 1):13-8. PubMed ID: 11256943
[TBL] [Abstract][Full Text] [Related]
15. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
[TBL] [Abstract][Full Text] [Related]
16. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.
Olsburgh J; Harnden P; Weeks R; Smith B; Joyce A; Hall G; Poulsom R; Selby P; Southgate J
J Pathol; 2003 Jan; 199(1):41-9. PubMed ID: 12474225
[TBL] [Abstract][Full Text] [Related]
17. Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases.
Kong XT; Deng FM; Hu P; Liang FX; Zhou G; Auerbach AB; Genieser N; Nelson PK; Robbins ES; Shapiro E; Kachar B; Sun TT
J Cell Biol; 2004 Dec; 167(6):1195-204. PubMed ID: 15611339
[TBL] [Abstract][Full Text] [Related]
18. Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease.
Stahlschmidt J; Varley CL; Toogood G; Selby PJ; Southgate J
Kidney Int; 2005 Sep; 68(3):1032-40. PubMed ID: 16105033
[TBL] [Abstract][Full Text] [Related]
19. Uroplakin traffic through the Golgi apparatus induces its fragmentation: new insights from novel in vitro models.
Višnjar T; Chesi G; Iacobacci S; Polishchuk E; Resnik N; Robenek H; Kreft M; Romih R; Polishchuk R; Kreft ME
Sci Rep; 2017 Oct; 7(1):12842. PubMed ID: 28993693
[TBL] [Abstract][Full Text] [Related]
20. Utility of uroplakin II expression as a marker of urothelial carcinoma.
Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
